Anti-psychotic drugs useful for severe depression
Key points
- Treatment with anti-psychotic agents, such as Risperdal (risperidone) or Geodon (ziprasidone), is useful for patients with severe depression who have failed to respond to conventional therapy, new researcher suggests.
- In patients with treatment-resistant major depressive disorder, treatment with olanzapine, risperidone, quetiapine or ziprasidone is often beneficial, according to researchers.
- Barbee told AMN Health that the "strategy of using (these drugs) as antidepressant augmentation agents was very effective - 65 percent of the patients responded to one drug or the other...This offers hope to the many patients who have not responded to other forms of antidepressant therapy."
- As reported in the Journal of Clinical Psychiatry, Barbee of Louisiana State University Health Sciences Center, New Orleans and colleagues describe their review of 49 patients given various anti-psychotic agents to control their severe depression.
Treatment with anti-psychotic agents, such as Risperdal (risperidone) or Geodon (ziprasidone), is useful for patients with severe depression who have failed to respond to conventional therapy, new researcher suggests. However, it may take a while to find one that works.
In patients with treatment-resistant major depressive disorder, treatment with olanzapine, risperidone, quetiapine or ziprasidone is often beneficial, according to researchers.
Lead investigator Dr. James G. Barbee told AMN Health that the "strategy of using (these drugs) as antidepressant augmentation agents was very effective - 65 percent of the patients responded to one drug or the other...This offers hope to the many patients who have not responded to other forms of antidepressant therapy."
As reported in the Journal of Clinical Psychiatry, Barbee of Louisiana State University Health Sciences Center, New Orleans and colleagues describe their review of 49 patients given various anti-psychotic agents to control their severe depression.
Individual response rates ranged from 57 percent of patients given Zyprexa (olanzapine) to 10 percent given Geodon.
An important finding, Barbee added, "was a validation of the principle of 'try, try again.'" Even when one anti-psychotic did not work, there was a good probability of success with subsequent trials of other drugs.
SOURCE: Journal of Clinical Psychiatry, July 2004.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Mental Health →GuidePregnancy and prescribing antipsychotics
Guidelines for prescribing antipsychotics during pregnancy and lactation include the following: 1. Consider nondrug options 2. Avoid drugs if possible during weeks 6–10 3. Use antipsychotics about which most is known…
13 May 2009
GuideAntipsychotic treatment response and serum levels in men and women
Genetics, age, height, weight, lean-fat ratio, diet, exercise, concurrent disease, smoking and alcohol, and the administration of concomitant drugs all contribute to antipsychotic drug response, as does end-organ…
13 May 2009
GuideSchizophrenia Typical & Atypical Antipsychotic Medication
Typical Antipsychotic Medication The first medications designed to treat schizophrenia are now called typical antipsychotic medications, or first-generation antipsychotics. Many of these early medications are still used…
